Pseudotuberculosis (Yersinia pseudotuberculosis Infection) Differential Diagnoses

1. Quan, TJ. Yersinial Infections Other Than Plague. Collier L, Balows A, Sussman M. Topley & Wilson's Microbiology and Microbial Infections. 9th. London, UK: Arnold; 1998. 3 Bacterial Infections: 905-918.

2. Amphlett A. Far East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen A. Open Forum Infect Dis. 2016 Jan. 3 (1):ofv202. [Medline].

3. Kaasch AJ, Dinter J, Goeser T, Plum G, Seifert H. Yersinia pseudotuberculosis bloodstream infection and septic arthritis: case report and review of the literature. Infection. 2012 Apr. 40 (2):185-90. [Medline].

4. Miller HK, Schwiesow L, Au-Yeung W, Auerbuch V. Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System. Front Cell Infect Microbiol. 2016. 6:69. [Medline].

5. Timchenko NF, Adgamov RR, Popov AF, Psareva EK, Sobyanin KA, Gintsburg AL, et al. Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia. Emerg Infect Dis. 2016 Mar. 22 (3):503-6. [Medline].

6. Horinouchi T, Nozu K, Hamahira K, Inaguma Y, Abe J, Nakajima H, et al. Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics. BMC Pediatr. 2015 Nov 11. 15 (1):177. [Medline].

7. McNally A, Thomson NR, Reuter S, Wren BW. 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution. Nat Rev Microbiol. 2016 Mar. 14 (3):177-90. [Medline].

8. Demeure CE, Derbise A, Carniel E. Oral vaccination against plague using Yersinia pseudotuberculosis. Chem Biol Interact. 2017 Apr 1. 267:89-95. [Medline].

9. Atkinson S, Williams P. Yersinia virulence factors - a sophisticated arsenal for combating host defences. F1000Res. 2016. 5:5-10. [Medline].

10. Galindo CL, Rosenzweig JA, Kirtley ML, Chopra AK. Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis. J Pathog. 2011. 2011:182051. [Medline].

11. May AN, Piper SM, Boutlis CS. Yersinia intussusception: case report and review. J Paediatr Child Health. 2014 Feb. 50 (2):91-5. [Medline].

12. Magistrali CF, Cucco L, Pezzotti G, Farneti S, Cambiotti V, Catania S, et al. Characterisation of Yersinia pseudotuberculosis isolated from animals with yersiniosis during 1996-2013 indicates the presence of pathogenic and Far Eastern strains in Italy. Vet Microbiol. 2015 Oct 22. 180 (1-2):161-6. [Medline].

13. Bonardi S, Bruini I, D'Incau M, Van Damme I, Carniel E, Brémont S, et al. Detection, seroprevalence and antimicrobial resistance of Yersinia enterocolitica and Yersinia pseudotuberculosis in pig tonsils in Northern Italy. Int J Food Microbiol. 2016 Oct 17. 235:125-32. [Medline].

14. Le Guern AS, Martin L, Savin C, Carniel E. Yersiniosis in France: overview and potential sources of infection. Int J Infect Dis. 2016 May. 46:1-7. [Medline].

15. Williamson DA, Baines SL, Carter G, Gonçalves da Silva A, Ren X, Sherwood J, et al. Genomic insights into a sustained national outbreak of Yersinia pseudotuberculosis. Genome Biol Evol. 2017 Jan 9. 17(2):120-1. [Medline].

16. Zalmover IIu. [Results of a 8-year study on clinical picture of Far East scarlatinoid fever]. Sov Med. 1969 Dec. 32 (12):93-7. [Medline].

17. Sato K, Ouchi K, Komazawa M. Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children. Pediatr Infect Dis J. 1988. 7:686.

18. Tauxe RV. Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis. UpToDate. Available at https://uptodate.com/contents/treatment-and-prevention-of-yersinia-enterocolitica-and-yersinia-pseudotuberculosis. Jul 14, 2015; Accessed: Mar 24, 2017.

19. Yersinia pseudotuberculosis infection. microbewiki. Available at https://microbewiki.kenyon.edu/index.php/Yersinia_pseudotuberculosis_infections. Accessed: May 15, 2017.

20. Slee KJ, Brightling P, Seiler RJ. Enteritis in cattle due to Yersinia pseudotuberculosis infection. Aust Vet J. 1988 Sep. 65 (9):271-5. [Medline].

David R Haburchak, MD, FACP Professor Emeritus of Medicine, Department of Medicine, Division of Infectious Diseases, Medical College of Georgia at Augusta University; Key Faculty, Wellstar Kennestone Internal Medicine Residency Program, Wellstar Health System

David R Haburchak, MD, FACP is a member of the following medical societies: American College of Physicians, American Osler Society, American Society for Microbiology, Christian Medical and Dental Associations, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Joseph F John, Jr, MD, FACP, FIDSA, FSHEA Clinical Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina College of Medicine; Associate Chief of Staff for Education, Ralph H Johnson Veterans Affairs Medical Center

Joseph F John, Jr, MD, FACP, FIDSA, FSHEA is a member of the following medical societies: Charleston County Medical Association, Infectious Diseases Society of America, South Carolina Infectious Diseases Society

Disclosure: Nothing to disclose.

Mark R Wallace, MD, FACP, FIDSA Infectious Disease Physician, Skagit Valley Hospital, Skagit Regional Health

Disclosure: Nothing to disclose.

Hari Polenakovik, MD, FACP, FIDSA Professor of Medicine, Wright State University, Boonshoft School of Medicine

Hari Polenakovik, MD, FACP, FIDSA is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Society for Microbiology, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

Asim A Jani, MD, MPH, FACP Clinician-Educator and Epidemiologist, Consultant and Senior Physician, Florida Department of Health; Diplomate, Infectious Diseases, Internal Medicine and Preventive Medicine

Asim A Jani, MD, MPH, FACP is a member of the following medical societies: American Association of Public Health Physicians, American College of Physicians, American College of Preventive Medicine, American Medical Association, American Public Health Association, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Paul Chen University of Texas Southwestern Medical School

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article